Athersys talking to ‘new potential partners’ for its stem cell technology


For months, Athersys has been restructuring its operations and trying to raise cash to complete the testing and commercialization of MultiStem.

Previous Josh Shapiro intervenes in Delaware County Memorial Hospital dispute, wants Prospect held in contempt
Next Sanford and Fairview Health rekindle merger conversation after 10 years